Business · 24/05/2022
FDA Revokes Emergency Use Authorization for COVID-19 Diagnostic Test
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for a COVID-19 diagnostic test developed by Clinical Research Sequencing Platform (CRSP), LLC, in partnership with the Broad Institute of MIT and Harvard.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →